Cannabinoid type 1 receptor gene polymorphism and macronutrient intake

Journal of Nutrigenetics and Nutrigenomics

Volumn 5, Issue 6, 2013, Pages 305-313

  Caruso, Maria Gabriella ^a   Gazzerro, Patrizia ^b   Notarnicola, Maria ^a   Cisternino, Anna Maria ^a   Guerra, Vito ^a   Misciagna, Giovanni ^a   Laezza, Chiara ^c   Bifulco, Maurizio ^b  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c CNR   (Italy)

Author keywords

Cannabinoid receptor; Gene polymorphism; Nutrients; Phenotype; Population study

Indexed keywords

CANNABINOID 1 RECEPTOR; CARBOHYDRATE; CHOLESTEROL; SATURATED FATTY ACID; POLYUNSATURATED FATTY ACID;

AGED; ALLELE; ARTICLE; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CHOLESTEROL INTAKE; CONTROLLED STUDY; DIETARY INTAKE; DNA POLYMORPHISM; FAT INTAKE; FEEDING BEHAVIOR; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENOTYPE; GROUPS BY AGE; HEALTH SURVEY; HETEROZYGOTE; HUMAN; ITALY; MACRONUTRIENT; MALE; MODEL; PRIORITY JOURNAL; RECEPTOR GENE; WILD TYPE; ADULT; CALORIE; GENETIC POLYMORPHISM; MAJOR CLINICAL STUDY;

ADULT; AGED; DIET SURVEYS; EATING; FEMALE; FOOD PREFERENCES; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RECEPTOR, CANNABINOID, CB1;

EID: 84870292042     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000343563     Document Type: Article

References (34)

1. Engeli S: Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight. Handb Exp Pharmacol 2012; 209:357-381.
2. Pagot to U, Pasquali R: Endoca nnabinoids and energ y metabolism. J Endocrinol Invest 2006; 29: 66-76.
3. Di Marzo V, Matias I: Endocannabinoid control of food intake and energy balance. Nat Neurosci 2005; 8: 585-589. (Pubitemid 40594198)
4. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R: The emerging role of the endocannabinoid system in endocrine regu lation and energy balance. Endocr Rev 2006; 23: 73-100. (Pubitemid 43228239)
5. Engeli S, Jana B, Mareike F, Kerstin G, Jurgen J, Sandor B: Activation of the peripheral endocannabinoid system in human obesity. Diabetes 2005; 54:2838-2843. (Pubitemid 41401077)
6. Ravinet TC, Delgorge C, Menet C, Arnone M, Soubrie P: CB1 cannabinoid receptor knockout in mice leads to leanness, resista nce to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 2004; 28: 640-648. (Pubitemid 38491158)
7. Lazzari P, Sanna A, Mastinu A, Cabasino S, Manca I, Pani L: Weight loss induced by rimonabant is associated with an altered leptin expression and hypothalamic leptin signaling in diet-induced obese mice. Behav Brain Res 2010; 217: 432-438.
8. Leite CE, Mocelin CA, Petersen GO, Leal MB, Thiesen FV: Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity. Pharmacol Rep 2009; 61:217-224.
9. Harrold JA, Elliott JC, King PJ, Widdowson PS, Williams G: Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res 2002; 952: 232-238.
10. Di Marzo V, Bifulco M, De Petrocellis L: The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 2004; 3:771-784. (Pubitemid 39242829)
11. Felder CC, Glass M: Cannabinoid receptors and their endogenous agonists. Ann Rev Pharmacol Toxicol 1998; 38: 179-200. (Pubitemid 28231493)
12. Aberle J, Flitsch J, Alessia N, Mann O, Busch P, Peitsmeier P, et al: Genetic variation may influence obesity only under conditions of diet: analysis of three candidate genes. Mol Genet Metab 2008; 95: 188-191.
13. Benzinou M, Chèvre JC, Ward KJ, Lecoeur C, Dina C, Lobbens S, et al: Endocannabinoid receptor 1 gene variations increase risk for obesity and modu late body mass index in European populations. Hum Mol Genet 2008; 17: 1916-1921. (Pubitemid 351865840)
14. Jaeger J, Mattevi V, Callegari-Jacques SD, Hutz MH: Cannabinoid type 1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population. Dis Markers 2008; 25:67-74.
15. Peeters A, Beckers S, Mertens I, Van Hul W, Van Gaal L: The G1422A variant of the endocannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men. Endocrine 2007; 31:138-141. (Pubitemid 350195147)
16. Russo P, Strazzullo P, Cappuccio F, Tregouet D, Lauria F, Loguercio M, et al: Genetic variations at the endocannabi-noid type 1 receptor gene (CRN1) are associated with obesity phenotypes in men. J Clin Endocrinol Metab 2007; 92: 2382-2389.
17. Gazzerro P, Caruso MG, Notarnicola M, Misciagna G, Guerra V, Laezza C, et al: Association between cannabinoid type 1 receptor polymorphism and body mass index in a southern Italian population. Int J Obes 2007; 31:908-912. (Pubitemid 46842680)
18. Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, et al: Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 1997; 132: 104-106. (Pubitemid 27303746)
19. Simiand J, Keane M, Keane PE, Soubrie P: SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food inta ke in marmoset. Behav Pharmacol 1998; 9: 179-181. (Pubitemid 28186515)
20. Foltin RW, Haney M: Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates. Pharmacol Biochem Behav 2007; 86:766-773. (Pubitemid 46839130)
21. Escartín-Pérez RE, Cendejas-Trejo NM, Cruz-Martínez AM, González-Hernández B, Mancilla-Díaz JM, Florán-Gar-duño B: Role of cannabinoid CB1 receptors on macronutrient selection and satiety in rats. Physiol Behav 2009; 96: 646-650.
22. Fidanza F: Nutrizione Umana. Napoli, Idelson, 1984.
23. Leoci C, Centonze S, Guerra V, Cisternino AM, Misciagna G: Reliability and validity of a semiquantitative food fre-quenc y questionnaire. G Ital Nutr Clin Prev 1993; 2: 58-59.
24. Misciagna G, Centonze S, Leoci C, Guerra V, Cisternino AM, Ceo R, et al: Diet, physical activity, and gallstones: a population-based case-control study in southern Italy. Am J Clin Nutr 1999; 69:120-126. (Pubitemid 29031261)
25. Pierucci P, Misciagna G, Ventura MT, Inguaggiato R, Cisternino AM, Guerra VM, et al: Diet and myocardial infarction: a nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy. Nutr Metab Cardiovasc Dis 2012; 22:727-733.
26. Schimdt LG, Samochowiec J, Finckh U, Fiszer-Piosik E, Horodnicki JB, Rommelspacher H, et al: Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 2002; 65: 221-224. (Pubitemid 34159069)
27. Heaney RP: Nutrient effects: discrepancy between data from controlled trials and observational studies. Bone 1997; 21:469-471. (Pubitemid 28029687)
28. Finkelstein DI, Reeves AK, Horne MK: An electron microscopic tracer study of the projections from entopeduncular nucleus to the ventrolateral nucleus of the rat. Neurosci Lett 1996; 211:33-36. (Pubitemid 26228021)
29. Pecina S, Berridge KC: Opioid sites in nucleus accumbens shell mediate eating and hedonic liking for food: map based on microinjection Fos plumes. Brain Res 2000; 863: 71-86. (Pubitemid 30201586)
30. Harrold JA, Williams G, Widdowson PS: Early leptin response to a palatable diet predicts dietary obesity in rats: key role of melanocortin-4-receptors in the ventromedial hypothalamic nucleus. J Neurochem 2000; 74:1224-1228. (Pubitemid 30104320)
31. Di Marzo V, Berrendero F, Bisogno T, Gonzales S, Cavaliere P, Romero J, et al: Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents of the striatum of A9-tetrahydrocannabinol-tolerant rats. J Neurochem 2000; 74:1627-1635. (Pubitemid 30163985)
32. Mechoulam R, Ben-Shabat S, Hanus L, Liqumsky M, Kaminski NE, Schatz AR, et al: Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995; 50:83-90.
33. Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V: Anandamide and diet: inclusion of dietary arachi-donate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci USA 2001; 98:6402-6406. (Pubitemid 32488249)
34. Matias I, Petrosino S, Racioppi A, Capasso R, Izzo AA, Di Marzo V: Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets. Mol Cell Endocrinol 2008; 286(suppl 1):S66-S78.